Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/54517
Title: FGFR1 Amplification and response to neoadjuvant anti-HER2 treatment in early HER2-positive breast cancer
Authors: 
Filiation: Servicio de Oncología. Hospital Universitario de Fuenlabrada
Servicio de Anatomía Patológica. Hospital Universitario de Fuenlabrada
Mesh: 
Decs: 
Issue Date: 24-Jan-2022
Publisher: MDPI AG
Citation: Gaibar M, Novillo A, Romero-Lorca A, Malon Gimenez D, Anton Pascual B, Moreno Torres A, et al. FGFR1 Amplification and response to neoadjuvant anti-HER2 Treatment in early HER2-positive breast cancer. Pharmaceutics. 2022;14(2):242.
URI: https://hdl.handle.net/20.500.12530/54517
Rights: info:eu-repo/semantics/openAccess
Appears in Collections:Hospitales > H. U. de Fuenlabrada > Artículos

Files in This Item:
File Description SizeFormat 
Pharmaceutics.pdf242.47 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons